These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 27604109

  • 1. Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series.
    Zandieh S, Bernt R, Mirzaei S, Haller J, Hergan K.
    J Nucl Cardiol; 2018 Aug; 25(4):1128-1134. PubMed ID: 27604109
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY, Carter SV, Flatley E, Ward RP, Moss JD, Appelbaum DE, Singh A, Lang RM, Tung R, Patel AR.
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
    [Abstract] [Full Text] [Related]

  • 3. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Palmisano A, Miller MA, Lala A, Chang HL, Sanz J, Contreras J, Narula J, Fuster V, Padilla M, Fayad ZA, Kovacic JC.
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [Abstract] [Full Text] [Related]

  • 4. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.
    Wisenberg G, Thiessen JD, Pavlovsky W, Butler J, Wilk B, Prato FS.
    J Nucl Cardiol; 2020 Dec; 27(6):2118-2129. PubMed ID: 30603887
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/18F-fluorodeoxyglucose positron emission tomography examinations.
    Tanaka TD, Nagai T, Nagoshi T, Yoshimura M.
    J Nucl Cardiol; 2020 Dec; 27(6):2149-2153. PubMed ID: 31773564
    [Abstract] [Full Text] [Related]

  • 6. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.
    Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E, Miura M, Sakaue S, Tamaki N, Nishimura M.
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):933-41. PubMed ID: 18084757
    [Abstract] [Full Text] [Related]

  • 7. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
    Greulich S, Gatidis S, Gräni C, Blankstein R, Glatthaar A, Mezger K, Müller KAL, Castor T, Mahrholdt H, Häntschel M, Hetzel J, Dittmann H, Nikolaou K, Gawaz M, la Fougère C, Krumm P.
    JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
    [Abstract] [Full Text] [Related]

  • 8. 11C-4DST PET/CT Imaging of Cardiac Sarcoidosis: Comparison With 18F-FDG and Cardiac MRI.
    Hotta M, Minamimoto R, Kubota S, Awaya T, Hiroi Y.
    Clin Nucl Med; 2018 Jun; 43(6):458-459. PubMed ID: 29538030
    [Abstract] [Full Text] [Related]

  • 9. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
    Lu Y, Grant C, Xie K, Sweiss NJ.
    Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic utility of fusion 18F-fluorodeoxyglucose positron emission tomography/cardiac magnetic resonance imaging in cardiac sarcoidosis.
    Okune M, Yasuda M, Soejima N, Kagioka Y, Kakehi K, Kawamura T, Hanaoka K, Kaida H, Ishii K, Nakazawa G, Miyazaki S, Iwanaga Y.
    J Nucl Cardiol; 2022 Apr; 29(2):753-764. PubMed ID: 33000410
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
    Wicks EC, Menezes LJ, Barnes A, Mohiddin SA, Sekhri N, Porter JC, Booth HL, Garrett E, Patel RS, Pavlou M, Groves AM, Elliott PM.
    Eur Heart J Cardiovasc Imaging; 2018 Jul 01; 19(7):757-767. PubMed ID: 29319785
    [Abstract] [Full Text] [Related]

  • 12. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H, Birnie DH, Pena E, Bernick J, Mc Ardle B, Leung E, Wells GA, Yoshinaga K, Tsujino I, Sato T, Manabe O, Oyama-Manabe N, Nishimura M, Tamaki N, Dick A, Dennie C, Klein R, Renaud J, deKemp RA, Ruddy TD, Chow BJW, Davies R, Hessian R, Liu P, Beanlands RSB, Nery PB.
    Eur J Nucl Med Mol Imaging; 2016 Feb 01; 43(2):259-269. PubMed ID: 26359191
    [Abstract] [Full Text] [Related]

  • 13. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
    Orii M, Hirata K, Tanimoto T, Ota S, Shiono Y, Yamano T, Matsuo Y, Ino Y, Yamaguchi T, Kubo T, Tanaka A, Akasaka T.
    Heart Rhythm; 2015 Dec 01; 12(12):2477-85. PubMed ID: 26111805
    [Abstract] [Full Text] [Related]

  • 14. Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging.
    Kataoka S, Momose M, Fukushima K, Serizawa N, Suzuki A, Kondo C, Abe K, Sakai S, Hagiwara N.
    Ann Nucl Med; 2017 Feb 01; 31(2):135-143. PubMed ID: 27804054
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of myocardial 2-[18F]fluoro-2-deoxy-D-glucose uptake is a typical feature in cardiac sarcoidosis: a study of 231 patients.
    Schildt JV, Loimaala AJ, Hippeläinen ET, Ahonen AA.
    Eur Heart J Cardiovasc Imaging; 2018 Mar 01; 19(3):293-298. PubMed ID: 28950301
    [Abstract] [Full Text] [Related]

  • 16. Comparing the diagnostic performance of [18F]FDG PET/CT and [18F]FDG PET/MRI for detecting cardiac sarcoidosis: A meta-analysis.
    Shen Y, Yang Y.
    Clin Imaging; 2024 Sep 01; 113():110248. PubMed ID: 39096887
    [Abstract] [Full Text] [Related]

  • 17. Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica.
    Owen CE, Poon AMT, Lee ST, Yap LP, Zwar RB, McMenamin CM, Lam SKL, Liew DFL, Pathmaraj K, Kemp A, Scott AM, Buchanan RRC.
    Rheumatology (Oxford); 2018 Feb 01; 57(2):345-353. PubMed ID: 29121248
    [Abstract] [Full Text] [Related]

  • 18. Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis.
    Trivieri MG, Robson PM, Vergani V, LaRocca G, Romero-Daza AM, Abgral R, Devesa A, Azoulay LD, Karakatsanis NA, Parikh A, Panagiota C, Palmisano A, DePalo L, Chang HL, Rothstein JH, Fayad RA, Miller MA, Fuster V, Narula J, Dweck MR, Morgenthau A, Jacobi A, Padilla M, Kovacic JC, Fayad ZA.
    JACC Cardiovasc Imaging; 2024 Apr 01; 17(4):411-424. PubMed ID: 38300202
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis.
    Sgard B, Brillet PY, Bouvry D, Djelbani S, Nunes H, Meune C, Valeyre D, Soussan M.
    Clin Radiol; 2019 Jan 01; 74(1):81.e9-81.e18. PubMed ID: 30482560
    [Abstract] [Full Text] [Related]

  • 20. 18F-FDG PET/CT for the assessment of myocardial sarcoidosis.
    Skali H, Schulman AR, Dorbala S.
    Curr Cardiol Rep; 2013 Apr 01; 15(4):352. PubMed ID: 23544184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.